FDA rules: NMN belongs to you, not pharma. Celebrate with $80 off Signal annual plans for a limited time
Dear Elysium Community,
Last week, the FDA confirmed that NMN—the main ingredient in our market-leading product Signal—is a dietary supplement. While we anticipated this outcome, as we always thought NMN was rightfully classified as a supplement, it is still cause for celebration.
Why did this happen? A pharmaceutical company recognized the incredible potential of NMN and petitioned the FDA to remove it from the consumer market, despite it being a natural compound. We believed this petition was without merit and entirely motivated by a desire to monopolize this powerful NAD+-boosting compound for their sole benefit. For nearly three years, Elysium and other industry leaders advocated for consumers’ right to use this incredible product, and we were victorious.
Our research shows that Signal stands apart from all other NMN products—the only one that has been shown to reverse biological aging. This FDA decision ensures that no pharmaceutical company can take Signal or NMN away from you.
To celebrate, we are giving you our best savings on Signal of the year—$80 off annual plans until October 13. If you would like to upgrade or extend your existing Signal subscription to take advantage of this limited-time offer, you can log into your account here.
*$80 off a Signal annual subscription will automatically apply at checkout—no code needed. Valid on new purchases only and valid only in the U.S. through 10/13/25 at 11:59PM PT.
